Cart
0

Epigenetics Market by Product [Enzymes (DNA Ligases, DNA Polymerases, Other DNA-modifying Enzymes), Kits & Assays (Bisulfite Conversion Kits, Chip-Seq Kits, Deep Sequencing Kits, Methyltransferase Assays, Histone Assays, Immunoprecipitation Kits), Instruments (Mass Spectrometers, Next-generation Sequencers, qPCRs, and Sonicators), and Reagents (Antibodies, Buffers, Histones, Magnetic Beads, Primers, and Other Epigenetics Reagents)], Application (Oncology and Non-oncology Diseases, Developmental Biology, Drug Discovery, and Others), and End User [Academic & Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Contract Research Organizations (CROs)] - Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_17846
Pages: 185
May 2017 | 3414 Views
 
Author's : Onkar Sumant and Sohail Shaikh
Tables: 98
Charts: 61
 

Epigenetics Market Overview:

Global Epigenetics Market was valued at $555 million in 2016, and is estimated to reach at $1,321 million by 2023, registering a CAGR of 13.1% from 2017 to 2023. Epigenetics is an extension of genetics and developmental biology, which involves study of cellular and physiological trait variations initiated by external or environmental stimuli. Epigenetics deals with changes in gene expression caused by certain base pairs in DNA & RNA, which are “turned off” or “turned on”, through chemical reactions contrary to being affected by changes in the nucleotide sequence. Epigenetic alterations result into change in phenotype, with the genotype of the organism being constant. Epigenetics changes are influenced by different factors, such as age, surrounding environment, lifestyle, disease state, and others.

DNA methylation and histone modification for instance are epigenetic processes wherein the alteration in gene expression is observed without the change in the DNA sequence. Rise in cancer prevalence; improved funding & aids for R&D activities, surge in partnership between academic, pharmaceutical, and biotechnology companies, and increased application of epigenetics in non-oncology diseases are the key factors that propel the growth of this market.

Global Epigenetics Market Segmentation

GLOBAL EPIGENETICS MARKET SEGMENTATION

Get more information on this report : Request Sample Pages

The epigenetics market is segmented based on product, application, end user, and geography. Based on product, it is divided into enzymes, kits & assays, instruments, and, reagents. Enzymes are further classified into DNA ligases, DNA polymerases, other DNA-modifying enzymes, acetylases, methyltransferases, other protein-modifying enzymes, reverse transcriptase, RNA ligases, and other RNA-modifying enzymes. Kits & assays are further subdivided into bisulfite conversion kits, chip-seq kits, deep sequencing kits, methyltransferase assays, histone assays, immunoprecipitation kits, and other epigenetic kits. Based on instruments, the market is further sub segmented into mass spectrometers, next-generation sequencers, qPCRs, and sonicators & other instruments. Based on reagents, it is categorized into antibodies, buffers, histones, magnetic beads, primers, and other epigenetics reagents.

On the basis of application, the market is bifurcated into oncology and non-oncology. Oncology is further sub-segmented into solid tumors & liquid tumors and non-oncology is further categorized into inflammatory diseases, metabolic diseases, infectious diseases, cardiovascular diseases, developmental biology, drug discovery, and other applications. On the basis of end user, the market is classified into academic & research institutes, pharmaceutical companies, biotechnology companies & contract research organizations (CROs). Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The market is expected to witness a moderate growth during the forecast period, owing to the rise in epigenetic drug discovery. Furthermore, surge in prevalence of cancer and technological advancements in epigenetics research are anticipated to augment the market growth. The untapped potential of emerging markets, such as China and India, is expected to present various opportunities for market expansion. However, high costs of instruments and dearth of skilled personnel are expected to hamper the market growth.

The report provides extensive competitive analysis and profiles of key market players, such as Abcam Plc., Illumina, QIAGEN N.V., Merck & Co., New England Biolabs, Inc., Epizyme Inc., Thermo Fisher Scientific, Inc., Active Motif. Diagenode, Inc., and Zymo Research Corporation.

The other players in the value chain include Domainex, CellCentric Ltd., Chroma Therapeutics Ltd., Eisai Co. Ltd., Novartis International AG, Oncolys Biopharma Inc., Syndax Pharmaceuticals, Inc., and Valirx plc.

Epigenetics Market, by Geography, 2016-2023 ($Million)

EPIGENETICS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

Get more information on this report : Request Sample Pages

Asia-Pacific possesses high market potential for the growth of epigenetics market, owing to high incidence of cancer and rise in healthcare expenditure. This region is anticipated to experience rapid market growth due to economic development.

India Epigenetics Market, 2016-2023 ($Million)

EPIGENETICS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

Get more information on this report : Request Sample Pages

India epigenetics market is projected to grow at a CAGR of 16.9% during the forecast period.

Key Benefits

  • This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
  • Market estimations are based on comprehensive analysis of the key developments in the industry.
  • In-depth analysis based on geography assists to understand the regional market and the strategic business planning.
  • The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Epigenetics Market Key Segments:

By Product

  • Enzymes
    • DNA Ligases
    • DNA Polymerases
    • Other DNA-modifying Enzymes
    • Acetylases
    • Methyltransferases
    • Other Protein-modifying Enzymes
    • Reverse Transcriptase
    • RNA Ligases
    • Other RNA-modifying Enzymes
  • Kits & Assays
    • Bisulfite Conversion Kits
    • Chip-seq Kits
    • Deep Sequencing Kits
    • Methyltransferase Assays
    • Histone Assays
    • Immunoprecipitation Kits
    • Other Epigenetic Kits
  • Instruments
    • Mass Spectrometers
    • Next-generation Sequencers
    • qPCRs
    • Sonicators
    • Other Instruments
  • Reagents
    • Antibodies
    • Buffers
    • Histones
    • Magnetic Beads
    • Primers
    • Other Epigenetics Reagents

By Application

  • Oncology
    • Solid Tumors
    • Liquid Tumors
  • Non-oncology
    • Inflammatory Diseases
    • Metabolic Diseases
    • Infectious Diseases
    • Cardiovascular Diseases
    • Developmental Biology
    • Drug Discovery
    • Others

By End User

  • Academic & Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil

    • Turkey

    • Saudi Arabia

    • South Africa

    • Rest of LAMEA

 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. TOP PLAYER POSITIONING
3.4. PATENTS ANALYSIS

3.4.1. Patent analysis by year
3.4.2. Patent analysis by region

3.5. PORTER’S FIVE FORCES ANALYSIS
3.6. MARKET DYNAMICS

3.6.1. Drivers
3.6.2. Restraints
3.6.3. Opportunities

Chapter: 4 GLOBAL EPIGENETICS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size & forecast

4.2. KITS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size & forecast
4.2.4. ChIP sequencing Kits

4.2.4.1. Market size and forecast

4.2.5. Bisulfite conversion kits

4.2.5.1. Market size and forecast

4.2.6. Whole genome amplification kits

4.2.6.1. Market size and forecast

4.2.7. 5-hmC & 5-mC analysis kits

4.2.7.1. Market size and forecast

4.2.8. RNA sequencing kits

4.2.8.1. Market size and forecast

4.2.9. Other epigenetics kits

4.2.9.1. Market size and forecast

4.3. REAGENTS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size & forecast
4.3.4. Antibodies

4.3.4.1. Market size and forecast

4.3.5. Magnetic beads

4.3.5.1. Market size and forecast

4.3.6. Histones

4.3.6.1. Market size and forecast

4.3.7. Buffers

4.3.7.1. Market size and forecast

4.3.8. Primers

4.3.8.1. Market size and forecast

4.3.9. Other epigenetics reagents

4.3.9.1. Market size and forecast

4.4. ENZYMES

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size & forecast
4.4.4. DNA Polymerase

4.4.4.1. Market size and forecast

4.4.5. Other DNA-modifying enzymes

4.4.5.1. Market size and forecast

4.4.6. DNA ligase

4.4.6.1. Market size and forecast

4.4.7. Methyltransferase

4.4.7.1. Market size and forecast

4.4.8. Acetylase

4.4.8.1. Market size and forecast

4.4.9. Reverse transcriptase

4.4.9.1. Market size and forecast

4.4.10. Other protein-modifying enzymes

4.4.10.1. Market size and forecast

4.4.11. RNA ligase

4.4.11.1. Market size and forecast

4.4.12. Other RNA-modifying enzymes

4.4.12.1. Market size and forecast

4.5. INSTRUMENTS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size & forecast
4.5.4. Next generation sequencer

4.5.4.1. Market size and forecast

4.5.5. qPCR

4.5.5.1. Market size and forecast

4.5.6. Mass spectrometer

4.5.6.1. Market size and forecast

4.5.7. Sonicator

4.5.7.1. Market size and forecast

4.5.8. Other instruments

4.5.8.1. Market size and forecast

Chapter: 5 ENERGY EPIGENETICS MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size & forecast

5.2. ONCOLOGY

5.2.1. Market size & forecast
5.2.1. Solid tumor

5.2.1.1. Market size and forecast

5.2.2. Liquid tumor

5.2.2.1. Market size and forecast

5.3. NON-ONCOLOGY

5.3.1. Market size & forecast
5.3.2. Metabolic disease

5.3.2.1. Market size and forecast

5.3.3. Infectious disease

5.3.3.1. Market size and forecast

5.3.4. Inflammatory disease

5.3.4.1. Market size and forecast

5.3.5. Cardiovascular disease

5.3.5.1. Market size and forecast

5.3.6. Other applications

5.3.6.1. Market size and forecast

Chapter: 6 GLOBAL EPIGENETICS MARKET, BY END USERS

6.1. OVERVIEW

6.1.1. Market size & forecast

6.2. ACADEMIC & GOVERNMENT RESEARCH INSTITUTE

6.2.1. Market size & forecast

6.3. PHARMACEUTICAL COMPANY

6.3.1. Market size & forecast

6.4. BIOTECHNOLOGY COMPANY

6.4.1. Market size & forecast

6.5. CONTRACT RESEARCH ORGANIZATION (CRO)

6.5.1. Market size & forecast

Chapter: 7 EPIGENETICS MARKET, BY GEOGRAPHY

7.1. OVERVIEW
7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size & forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size & forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size & forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. South Korea market size and forecast
7.4.3.6. Taiwan market size and forecast
7.4.3.7. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size & forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. Turkey market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast

Chapter: 8 COMPANY PROFILES

8.1. ILLUMINA, INC

8.1.1. Operating business segments
8.1.2. Business performance

8.2. THERMO FISHER SCIENTIFIC, INC

8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments

8.3. ABCAM PLC

8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments

8.4. EPIZYME, INC.

8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments

8.5. NEW ENGLAND BIOLABS, INC. (NEB)

8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments

8.6. QIAGEN N.V.,

8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments

8.7. MERCK & CO., (MERCK)

8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments

8.8. ACTIVE MOTIF

8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments

8.9. DIAGENODE, INC.

8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments

8.10. ZYMO RESEARCH CORPORATION (ZYMO)

8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL EPIGENETICS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 2. GLOBAL EPIGENETICS KITS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 3. EPIGENETICS CHIP SEQUENCING KITS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. EPIGENETICS BISULFITE CONVERSION KITS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 5. EPIGENETICS WHOLE GENOME AMPLIFICATION KITS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 6. EPIGENETICS 5-HMC & H-MC ANALYSIS KITS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 7. EPIGENETICS RNA SEQUENCING KITS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 8. OTHER EPIGENETICS KITS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 9. GLOBAL EPIGENETICS REAGENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 10. EPIGENETICS ANTIBODIES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 11. EPIGENETICS MAGNETIC BEADS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 12. EPIGENETICS HISTONES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 13. EPIGENETICS BUFFERS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 14. EPIGENETICS PRIMERS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 15. OTHER EPIGENETICS REAGENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 16. GLOBAL EPIGENETICS ENZYMES MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 17. EPIGENETICS DNA POLYMERASE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 18. EPIGENETICS OTHER DNA MODIFYING ENZYMES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 19. EPIGENETICS DNA LIGASE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 20. EPIGENETICS METHYLTRANSFERASE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 21. EPIGENETICS ACETYLASE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 22. EPIGENETICS REVERSE TRANSCRIPTASE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 23. EPIGENETICS OTHER PROTEIN-MODIFYING ENZYMES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 24. EPIGENETICS RNA LIGASE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 25. EPIGENETICS OTHER RNA MODIFYING ENZYMES ENZYMES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 26. GLOBAL EPIGENETICS INSTRUMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 27. EPIGENETICS NEXT GENERATION SEQUENCER MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 28. EPIGENETICS QPCR MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 29. EPIGENETICS MASS SPECTROMETER MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 30. EPIGENETICS SONICATOR MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 31. EPIGENETICSOTHER INSTRUMENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 32. GLOBAL EPIGENETICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 33. GLOBAL ONCOLOGY EPIGENETICS MARKET, BY APPLICATION TYPE, 2016-2023 ($MILLION)
TABLE 34. EPIGENETICS SOLID TUMOR MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 35. EPIGENETICS LIQUID TUMOR MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 36. GLOBAL NON-ONCOLOGY EPIGENETICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 37. EPIGENETICS METABOLIC DISEASE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 38. EPIGENETICS INFECTIOUS DISEASE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 39. EPIGENETICS INFLAMMATORY DISEASE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 40. EPIGENETICS CARDIOVASCULAR DISEASE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 41. EPIGENETICS OTHER APPLICATION MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 42. GLOBAL EPIGENETICS MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 43. ACADEMIC & GOVERNMENT RESEARCH INSTITUTE EPIGENETICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 44. PHARMACEUTICAL COMPANY EPIGENETICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 45. BIOTECHNOLOGY COMPANY EPIGENETICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 46. CRO EPIGENETICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 69. ASIA-PACIFIC EPIGENETICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 70. ASIA-PACIFIC EPIGENETICS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 71. ASIA-PACIFIC EPIGENETICS KITS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 72. ASIA-PACIFIC EPIGENETICS REAGENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 73. ASIA-PACIFIC EPIGENETICS ENZYMES MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 74. ASIA-PACIFIC EPIGENETICS INSTRUMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 75. ASIA-PACIFIC EPIGENETICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 76. ASIA-PACIFIC ONCOLOGY EPIGENETICS MARKET, BY APPLICATION TYPE, 2016-2023 ($MILLION)
TABLE 77. ASIA-PACIFIC NON-ONCOLOGY EPIGENETICS MARKET, BY APPLICATION TYPE, 2016-2023 ($MILLION)
TABLE 79. LAMEA EPIGENETICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 80. LAMEA EPIGENETICS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 81. LAMEA EPIGENETICS KITS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 82. LAMEA EPIGENETICS REAGENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 83. LAMEA EPIGENETICS ENZYMES MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 84. LAMEA EPIGENETICS INSTRUMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 85. LAMEA EPIGENETICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 86. LAMEA ONCOLOGY EPIGENETICS MARKET, BY APPLICATION TYPE, 2016-2023 ($MILLION)
TABLE 87. LAMEA NON-ONCOLOGY EPIGENETICS MARKET, BY APPLICATION TYPE, 2016-2023 ($MILLION)
TABLE 89. ILLUMINA, INC: COMPANY SNAPSHOT
TABLE 90. THERMO FISHER SCIENTIFIC, INC: COMPANY SNAPSHOT
TABLE 91. ABCAM PLC: COMPANY SNAPSHOT
TABLE 92. EPIZYME, INC.: COMPANY SNAPSHOT
TABLE 93. NEB: COMPANY SNAPSHOT
TABLE 94. QIAGEN N.V.: COMPANY SNAPSHOT
TABLE 95. MERCK: COMPANY SNAPSHOT
TABLE 96. ACTIVE MOTIF: COMPANY SNAPSHOT
TABLE 97. DIAGENODE, INC.: COMPANY SNAPSHOT
TABLE 98. ZYMO: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1. EPIGENETICS MARKET: MARKET SEGMENATION
FIGURE 2. TOP INVESTMENT POCKETS: GLOBAL DNA SEQUENCING MARKET, BY APPLICATION
FIGURE 3. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 5. TOP PLAYER POSITIONING: GLOBAL EPIGENETICS MARKET
FIGURE 6. PATENT ANALYSIS BY REGION
FIGURE 7. BARGAINING POWER OF BUYERS
FIGURE 8. BARGAINING POWER OF SUPPLIERS
FIGURE 9. THREAT OF NEW ENTRANTS
FIGURE 10. THREAT OF SUBSTITUTION
FIGURE 11. COMPETITIVE RIVALRY
FIGURE 12. EPIGENETICS MARKET: PRODUCT SEGMENATION
FIGURE 13. U.S. EPIGENETICS MARKET, 2016-2023 ($MILLION)
FIGURE 14. CANADA EPIGENETICS MARKET, 2016-2023 ($MILLION)
FIGURE 15. MEXICO EPIGENETICS MARKET, 2016-2023 ($MILLION)
FIGURE 16. GERMANY EPIGENETICS MARKET, 2016-2023 ($MILLION)
FIGURE 17. FRANCE EPIGENETICS MARKET, 2016-2023 ($MILLION)
FIGURE 18. UK EPIGENETICS MARKET, 2016-2023 ($MILLION)
FIGURE 19. ITALY EPIGENETICS MARKET, 2016-2023 ($MILLION)
FIGURE 20. SPAIN EPIGENETICS MARKET, 2016-2023 ($MILLION)
FIGURE 21. REST OF EUROPE EPIGENETICS MARKET, 2016-2023 ($MILLION)
FIGURE 22. JAPAN EPIGENETICS MARKET, 2016-2023 ($MILLION)
FIGURE 23. CHINA EPIGENETICS MARKET, 2016-2023 ($MILLION)
FIGURE 24. AUSTRALIA EPIGENETICS MARKET, 2016-2023 ($MILLION)
FIGURE 25. INDIA EPIGENETICS MARKET, 2016-2023 ($MILLION)
FIGURE 26. SOUTH KOREA EPIGENETICS MARKET, 2016-2023 ($MILLION)
FIGURE 27. TAIWAN EPIGENETICS MARKET, 2016-2023 ($MILLION)
FIGURE 28. REST OF ASIA-PACIFIC EPIGENETICS MARKET, 2016-2023 ($MILLION)
FIGURE 29. BRAZIL EPIGENETICS MARKET, 2016-2023 ($MILLION)
FIGURE 30. TURKEY EPIGENETICS MARKET, 2016-20223 ($MILLION)
FIGURE 31. SAUDI ARABIA EPIGENETICS MARKET, 2016-2023 ($MILLION)
FIGURE 32. REST OF LAMEA EPIGENETICS MARKET, 2016-2023 ($MILLION)
FIGURE 33. ILLUMINA, INC: NET SALES, 2014-2017 ($MILLION)
FIGURE 34. ILLUMINA, INC: REVENUE BY SEGMENT, 2015 (%)
FIGURE 35. THERMO FISHER SCIENTIFIC, INC: NET SALES, 2014-2017 ($MILLION)
FIGURE 36. THERMO FISHER SCIENTIFIC, INC: REVENUE BY SEGMENT, 2015 (%)
FIGURE 37. THERMO FISHER SCIENTIFIC, INC: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 38. ABCAM PLC: NET SALES, 2014-2017 ($MILLION)
FIGURE 39. ABCAM PLC.: REVENUE BY SEGMENT, 2015 (%)
FIGURE 40. ABCAM PLC.: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 41. EPIZYME, INC.: NET SALES, 2014-2017 ($MILLION)
FIGURE 42. EPIZYME, INC.: REVENUE BY SEGMENT, 2015 (%)
FIGURE 43. EPIZYME, INC.: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 44. NEB: NET SALES, 2014-2017 ($MILLION)
FIGURE 45. NEB: REVENUE BY SEGMENT, 2015 (%)
FIGURE 46. NEB: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 47. QIAGEN N.V: NET SALES, 2014-2017 ($MILLION)
FIGURE 48. QIAGEN N.V: REVENUE BY SEGMENT, 2015 (%)
FIGURE 49. QIAGEN N.V: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 50. MERCK: NET SALES, 2014-2017 ($MILLION)
FIGURE 51. MERCK: REVENUE BY SEGMENT, 2015 (%)
FIGURE 52. MERCK: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 53. ACTIVE MOTIF: NET SALES, 2014-2017 ($MILLION)
FIGURE 54. ACTIVE MOTIF: REVENUE BY SEGMENT, 2015 (%)
FIGURE 55. ACTIVE MOTIF: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 56. DIAGENODE, INC: NET SALES, 2014-2017 ($MILLION)
FIGURE 57. DIAGENODE, INC: REVENUE BY SEGMENT, 2015 (%)
FIGURE 58. DIAGENODE, INC: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 59. ZYMO: NET SALES, 2014-2017 ($MILLION)
FIGURE 60. ZYMO: REVENUE BY SEGMENT, 2015 (%)
FIGURE 61. ZYMO: REVENUE BY GEOGRAPHY, 2015 (%)

 

Epigenetics is the fundamental principle behind external DNA or RNA modifications that switch genes "on" or "off." These modifications do not alter the DNA or RNA sequence; however, they affect how cells read genes. A change in the phenotype rather than the genotype is observed through epigenetics. DNA methylation and histone modifications are some of the different examples of epigenetics. Epigenetics is also inherited from one generation to another and this area requires more credible research. Epigenetics has recently gained traction due to the role of epigenetic processes, especially DNA methylation, as a cancer risk marker.

Epigenetics has enhanced diverse fields of life sciences by research innovation and development. Oncology- and non-oncology-related investigation areas, such as developmental biology and drug discovery, are also anticipated to benefit through epigenetic interventions. Moreover, diagnostics, including inflammatory, metabolic, infectious, and cardiovascular disease research, is also expected to be positively impacted through epigenetics in the near future. The market has gained momentum in the research, innovation, and development sector, owing to the increase in cancer prevalence globally, significant technological advancements in epigenetics research, and surge in collaborations & partnerships among academic & research institutes and pharmaceutical & biotechnology companies globally. In addition, rise in investment in epigenetics research and innovation & development drive the market growth.

However, high cost of instruments and lack of trained professionals are the factors that restrain the growth of this market. At present, academic & government research institutes are the largest end users of epigenetics products, followed by pharmaceutical companies, biotechnology companies, and contract research organizations (CROs). The biotechnology end-user segment is expected to exhibit the highest growth rate throughout the forecast period. However, the utilization of epigenetics products is higher in academic & government research institutes as compared to other end users as epigenetic studies, such as acetylation, histone modification, DNA methylation, and other studies are facilitated in research in academic & government research institutes to a greater extent when compared with other end users. The employment of technologically advanced epigenetics products is highest in North America, owing to the increase in adoption of epigenetics products, followed by Europe and Asia-Pacific.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Epigenetics Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $3690
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4099
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $4999
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6004
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8373
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo